PanAsia Bio President Michael Xu: An Interview With PharmAsia News

Michael Xu, president of Shanghai-based PanAsia Bio, an emerging R&D-based biotech company, sat down recently with PharmAsia News' China Bureau to discuss the company's technology for drug delivery systems, mainly in PEG-based biomaterials. PEGylation is a process of attaching strands of polyethylene glycol (PEG) to molecules, mostly peptides, proteins and antibody fragments.